Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 GBX | -2.17% | -.--% | -3.57% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Sales 2022 | 403K 504K | Sales 2023 | 530K 663K | Capitalization | 5.17M 6.47M |
---|---|---|---|---|---|
Net income 2022 | -9M -11.26M | Net income 2023 | -5M -6.26M | EV / Sales 2022 | 8.48 x |
Net cash position 2022 | 13.99M 17.5M | Net cash position 2023 | 6.73M 8.42M | EV / Sales 2023 | -2.94 x |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-0.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.26% |
Latest transcript on ReNeuron Group plc
1 day | -2.17% | ||
6 months | -36.92% | ||
Current year | -3.57% |
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Hancock
COO | Chief Operating Officer | - | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 22-03-02 | |
Simon Dew
PRN | Corporate Officer/Principal | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Walton
BRD | Director/Board Member | 61 | 22-03-21 |
Iain Ross
CHM | Chairman | 71 | 21-06-30 |
Director/Board Member | 61 | 21-07-13 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.57% | 2.41M | |
+24.79% | 46.71B | |
+48.83% | 41.8B | |
-1.05% | 41.52B | |
-5.86% | 29.55B | |
+10.91% | 25.78B | |
-20.51% | 19.26B | |
+2.45% | 12.14B | |
-3.40% | 12.08B | |
+28.38% | 11.98B |
- Stock Market
- Equities
- RENE Stock